openPR Logo
Press release

Europe SGLT2 Inhibitors Market Opportunity, Challenge, Trend, Global Business Growth Forecast By 2023-2032 | AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company

10-15-2024 09:35 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Europe SGLT2 Inhibitors Market

Europe SGLT2 Inhibitors Market

Europe SGLT2 Inhibitors-Market Insights, Size Revenue, Outlook, Overview, and Analysis. ๐“๐ก๐ž ๐„๐ฎ๐ซ๐จ๐ฉ๐ž ๐’๐†๐‹๐“๐Ÿ ๐ข๐ง๐ก๐ข๐›๐ข๐ญ๐จ๐ซ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ’,๐Ÿ๐Ÿ’๐Ÿ.๐Ÿ—๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ•,๐Ÿ”๐Ÿ๐Ÿ—.๐Ÿ•๐Ÿ— ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ”.๐Ÿ•% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž:
This comprehensive study provides an accurate overview of the worldwide Europe SGLT2 inhibitors market. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by indication, drug, distribution channel, and country in the study, which offers a comprehensive picture of the state of the market.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market/request-for-sample

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
SGLT2 inhibitors are drugs that help manage type 2 diabetes by stopping the SGLT2 protein in the kidneys from reabsorbing glucose, leading to its removal through urine. Assisting in decreasing glucose levels in the body, it can also aid in weight loss and lowering blood pressure. They offer extra advantages for the heart and kidneys, proving useful in treating complications related to diabetes.
Drivers and Trends:
โ€ข With the aging population in Europe on the rise, there is a higher occurrence of chronic conditions like heart disease, diabetes, and cancer. It has led to an increasing need for SGLT2 inhibitors to manage chronic conditions, such as hypertension and type 2 diabetes.
โ€ข European administrations are putting in place a range of strategies like offering financial aid for diabetes drugs, enhancing healthcare availability, and focusing on preventative health services. These policies aim to improve diabetes treatment and control, ultimately promoting the widespread use of SGLT2 inhibitors.

๐“๐จ๐ฉ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ:
With so many businesses involved, the market is projected to become more competitive as it continues to grow.
Here are the top companies in the Europe SGLT2 inhibitors market:
โ€ข AstraZeneca
โ€ข Boehringer Ingelheim International GmbH
โ€ข Bristol-Myers Squibb Company
โ€ข Eli Lilly and Company
โ€ข Glenmark Pharmaceuticals Ltd.
โ€ข Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)
โ€ข Lexicon Pharmaceuticals, Inc.
โ€ข Merck & Co., Inc.
โ€ข Novo Nordisk
โ€ข Sanofi
โ€ข Pfizer Inc.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market/request-for-discount-pricing

๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐–๐ข๐ฌ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
According to regional analysis, the UK held the largest market share in 2023. The country's National Health Service (NHS) has a robust structure and broad access, making advanced diabetes treatments like SGLT2 inhibitors widely available.
Also, during the projection period, Germany is anticipated to experience substantial growth. The presence of top pharmaceutical companies and continuous research and development efforts have bolstered the availability and use of SGLT2 inhibitors in the country.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
๐๐ฒ ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Cardiovascular
โ€ข Chronic Kidney Disease (CKD)
โ€ข Type 2 Diabetes
โ€ข Others

๐๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Farxiga (Dapagliflozin)
โ€ข Inpefa (Sotagliflozin)
โ€ข Invokana (Canagliflozin)
โ€ข Jardiance (Empagliflozin)
โ€ข Qtern (Dapagliflozin/Saxagliptin)
โ€ข Other SGLT2 Inhibitors

๐๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Hospital Pharmacies
โ€ข Online Pharmacies
โ€ข Retail Pharmacies

๐๐ฒ ๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Germany
โ€ข France
โ€ข UK
โ€ข Italy
โ€ข Spain
โ€ข Netherlands
โ€ข Russia
โ€ข Rest of Europe

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐“๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž:
https://www.polarismarketresearch.com/industry-analysis/europe-sglt2-inhibitors-market

๐„๐ฎ๐ซ๐จ๐ฉ๐ž ๐’๐†๐‹๐“๐Ÿ ๐ˆ๐ง๐ก๐ข๐›๐ข๐ญ๐จ๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โ€ข In terms of drug, the Jardiance (Empagliflozin) segment accounted for the largest revenue share in the Europe SGLT2 inhibitors market in 2023. Major health organizations and regulatory bodies such as the European Medicines Agency (EMA) and the American Diabetes Association (ADA) recommend the use of Jardiance for the treatment of type 2 diabetes.
โ€ข The type 2 diabetes segment, by indication, is expected to register the highest CAGR during the forecast period. Governments and healthcare organizations in Europe are implementing policies and initiatives such as promoting early diagnosis through regular screenings, funding diabetes education programs, and subsidizing the cost of medications. Such measures increase accessibility and affordability of diabetes treatments, boosting market growth.
โ€ข In 2023, the UK accounted for the largest share of the Europe SGLT2 inhibitors market. The country hosts numerous prominent pharmaceutical companies and research institutions committed to advancing and commercializing treatments for diabetes.
โ€ข AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; Glenmark Pharmaceuticals Ltd.; Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.); Lexicon Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk; Sanofi; and Pfizer Inc. are among the key players in Europe.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐“๐ซ๐ข๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฌ๐จ๐ฎ๐ซ๐œ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/clinical-trials-outsourcing-market

๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐“๐š๐ฉ๐ž๐ฌ ๐š๐ง๐ ๐๐š๐ง๐๐š๐ ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/medical-tapes-and-bandages-market

๐Œ๐ข๐œ๐ซ๐จ๐›๐ข๐จ๐ฆ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ซ๐ž๐ฉ๐š๐ซ๐š๐ญ๐ข๐จ๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/microbiome-sample-preparation-technology-market

๐ˆ๐ฌ๐จ๐ญ๐ก๐ž๐ซ๐ฆ๐š๐ฅ ๐๐ฎ๐œ๐ฅ๐ž๐ข๐œ ๐€๐œ๐ข๐ ๐€๐ฆ๐ฉ๐ฅ๐ข๐Ÿ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/isothermal-nucleic-acid-amplification-technology-market

๐๐ซ๐จ๐ญ๐ž๐ข๐ง ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/protein-expression-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Europe SGLT2 Inhibitors Market Opportunity, Challenge, Trend, Global Business Growth Forecast By 2023-2032 | AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company here

News-ID: 3692786 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

AI in Chemicals Market Set to Reach USD 9,725.61 million by 2032 with a CAGR of 39.1%
10-15-2024 | IT, New Media & Software
Polaris Market Research & Consulting
AI in Chemicals Market Set to Reach USD 9,725.61 million by 2032 with a CAGR of โ€ฆ
๐€๐ˆ ๐ข๐ง ๐‚๐ก๐ž๐ฆ๐ข๐œ๐š๐ฅ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐’๐ข๐ณ๐ž ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐“๐ก๐ž ๐€๐ˆ ๐ข๐ง ๐œ๐ก๐ž๐ฆ๐ข๐œ๐š๐ฅ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ’๐Ÿ—๐Ÿ—.๐Ÿ—๐Ÿ“ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ—,๐Ÿ•๐Ÿ๐Ÿ“.๐Ÿ”๐Ÿ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ‘๐Ÿ—.๐Ÿ% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž: This comprehensive study provides an accurate overview of the worldwide AI in chemicals market. Comprehensive analyses of sales volume, price, revenue, market share, andโ€ฆ
Green Methanol Market Forecast: $ 16,870.7 Million by 2032 with a CAGR of 31.8%.
10-14-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Green Methanol Market Forecast: $ 16,870.7 Million by 2032 with a CAGR of 31.8%.
๐“๐ก๐ž ๐ ๐ซ๐ž๐ž๐ง ๐ฆ๐ž๐ญ๐ก๐š๐ง๐จ๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ,๐Ÿ’๐ŸŽ๐Ÿ—.๐Ÿ— ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘. ๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ๐Ÿ”,๐Ÿ–๐Ÿ•๐ŸŽ.๐Ÿ• ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ž๐ฑ๐ก๐ข๐›๐ข๐ญ๐ข๐ง๐  ๐š ๐œ๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐š๐ง๐ง๐ฎ๐š๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ‘๐Ÿ.๐Ÿ–% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง: Methanol that is green or renewable is made from different sources of biomass like forestry and agricultural leftovers, sewage, biogas, waste products, municipal solid waste (MSW), carbon dioxide, black liquor from pulpโ€ฆ
Building Information Modeling Market to Reflect USD 23.65 Billion By 2032 | Growing at a Healthy CAGR of 13.6%
10-14-2024 | IT, New Media & Software
Polaris Market Research & Consulting
Building Information Modeling Market to Reflect USD 23.65 Billion By 2032 | Grow โ€ฆ
๐๐ฎ๐ข๐ฅ๐๐ข๐ง๐  ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐Œ๐จ๐๐ž๐ฅ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ Market Outlook: โ— The building information modeling market size was valued at USD 7.54 billion in 2023. โ— The market is expected to expand at a CAGR of 13.6% from 2024 to 2032. โ— The market is expected to grow to USD 23.65 billion by 2032. ๐‚๐ก๐ž๐œ๐ค ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ: https://www.polarismarketresearch.com/industry-analysis/building-information-modeling-market/request-for-sample ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ: Building Information Modeling (BIM) technology revolutionizes the way buildings and infrastructure are planned, designed, constructed, and managed. It includes developingโ€ฆ
Massive growth of Process Spectroscopy Market by 2032 with key players such asย ABB,ย Agilent Technologies, Inc.,ย Bruker,ย BUCHI
10-14-2024 | IT, New Media & Software
Polaris Market Research & Consulting
Massive growth of Process Spectroscopy Market by 2032 with key players such asย  โ€ฆ
The process spectroscopy market size was valued at USD 20.54 billion in 2023. The market is projected to grow to USD 52.25 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.9% from 2024 to 2032. ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง: Process spectroscopy involves utilizing a spectrometer to oversee the production process of a sample item. Furthermore, this spectroscopy process is utilized in a wide range of spectrometry methods. Different types of spectroscopyโ€ฆ

All 5 Releases


More Releases for SGLT2

08-17-2022 | Health & Medicine
Future Market Insights
SGLT2 Inhibitors Treatment Market Current and Future Industry Landscape Analysis โ€ฆ
SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level. SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetesโ€ฆ
07-19-2022 | Health & Medicine
DelveInsight Business Research
SGLT2 Inhibitors Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "SGLT2 Inhibitors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of SGLT2 Inhibitors, historical and forecasted epidemiology as well as the SGLT2 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The SGLT2 Inhibitors market report provides current treatment practices, emerging drugs, SGLT2 Inhibitors market share of the individual therapies, and current and forecasted SGLT2 Inhibitors market sizeโ€ฆ
01-15-2018 | Health & Medicine
Transparency Market Research
Report Explores the SGLT2 Inhibitors Market Latest Trends and Insights by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโ€ฆ
08-24-2017 | Health & Medicine
TMR - Research Reports
SGLT2 Inhibitors Market Foreseen to Grow Exponentially by 2024
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโ€ฆ
05-22-2017 | IT, New Media & Software
TMR - Research Reports
Rising Prevalence of Diabetes Across the Globe is Expected to Drive the Global S โ€ฆ
Sodium glucose transporters are proteins responsible for reabsorption of glucose from kidneys. This protein family has two members: sodium glucose cotransporter-1 (SGLT1) and sodium glucose cotransporter-2 (SGLT2). SGLT2 is expected to reabsorb 90% of the glucose from kidneys, while SGLT1 absorbs the remaining 10%. SGLT2 inhibitors are drugs that affect the action of SGLT2 proteins, thereby reducing blood glucose levels. Hence, these are important in the treatment for type IIโ€ฆ
04-12-2017 | Health & Medicine
Transparency Market Research - Medical Devices
SGLT2 Inhibitors Market : Key Players and Production Information analysis with F โ€ฆ
SGLT2 inhibitors are expected to have high consumption in the near future due to simple treatment method and relatively better results and preferred line of treatment for type II diabetes. Additionally, rising prevalence of diabetes across the globe is expected to drive the global SGLT2 inhibitors market. According to the American Diabetes Association, approximately 25.8 million people were diagnosed with diabetes in 2010 which increased to 29.1 million in 2012โ€ฆ